Delivery Order SPE2DB22D3016-SPE2DB26FABL7
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a $1,611.45 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Quviviq 25 mg tablets (30-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,212.55 for Quiviviq 25 mg tablets (30-count packages) on September 25, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a $1,614.22 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count supply) on September 19, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a $1,877.08 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Quivivq 50 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QUVIVIQ 25 MG TABLET 30S. The contract has a firm fixed price of $1,027.28 and a performance period through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.20 to AmerisourceBergen Drug Corp for the supply of Quviviq 25 mg tablets (30-count package) under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately one thousand dollars to Amerisourcebergen Drug Corporation for 25mg Quviviq tablets. Under this order, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between September 20th and 21st of 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for the supply of fifty milligram Quviviq tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver thirty tablets of the specified medication to a facility in Conshohocken, Pennsylvania between August 11th and 14th, 2023. The Defense Logistics Agency routinely utilizes...